HIGHLIGHTS
- who: Artur Beberok from the (UNIVERSITY) have published the research: Interaction between moxifloxacin and Mcl-1 and MITF proteins: the effect on growth inhibition and apoptosis in MDA-MB-231 human triple-negative breast cancer cells, in the Journal: (JOURNAL)
- what: The aim of this study was to verify whether the interaction between moxifloxacin (MFLX) one of the fluoroquinolones and MITF/Mcl-1 protein could affect the viability proliferation and apoptosis in human breast cancer using both in silico and in vitro models. The analysis was performed according to a previously described protocol . In the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.